- Clinical trials are research studies testing whether a new COPD treatment is safe and effective; they are not guaranteed therapy.
- Drug trials generally move through phases (roughly 1 to 4), each answering a different question.
- ClinicalTrials.gov is the main US registry for finding COPD studies.
- Informed consent means full information, the chance to ask questions, and the right to withdraw at any time.
- Inclusion and exclusion criteria decide who can join a given trial.
- Talk with your pulmonologist before considering a trial, and never stop your inhalers or other treatment on your own to qualify.
Chronic obstructive pulmonary disease (COPD) is a long-term lung condition that makes breathing progressively harder, and research into new treatments is active, spanning inhaled medications, biologics, devices, pulmonary rehabilitation approaches, and strategies to reduce flare-ups (exacerbations). For some people, especially when COPD is not well controlled on standard treatment, a clinical trial can be a way to access investigational options while contributing to research. Trials are research studies, not guaranteed therapy. This guide explains how COPD clinical trials work, what the phases mean, how to find studies, and what informed consent involves, so you can prepare a good conversation with your pulmonologist.
What a clinical trial is
A clinical trial is a research study that tests a medical approach, such as a new medication, inhaler, biologic, or device, in people. It aims to answer specific questions: Is it safe? What dose works? Does it help more than existing options or a placebo? Because those answers are still being determined, participation involves uncertainty. Participants may benefit, but benefit is never guaranteed and is not the study’s only goal.
For COPD specifically, trials may test new bronchodilators or inhaled combinations, biologic therapies, treatments aimed at reducing exacerbations, oxygen or device strategies, or pulmonary rehabilitation and lifestyle interventions. Some studies focus on people with frequent flare-ups or more advanced disease.
The phases of drug trials
New drugs generally move through phases, each asking a different question.
| Phase | Main question | Typical scope |
|---|---|---|
| Phase 1 | Is it safe, and what dose is tolerable? | Small group of participants |
| Phase 2 | Does it appear to work, and what are the side effects? | Larger group |
| Phase 3 | Is it effective compared with standard care or placebo? | Large groups, often multiple sites |
| Phase 4 | What are the longer-term effects after approval? | Post-approval monitoring |
Many trials use randomization and a control group, and some are “blinded,” meaning participants (and sometimes researchers) do not know who receives the investigational treatment versus a comparison or placebo. These designs improve reliability but mean you may not receive the new treatment.
How to search for COPD trials
The main US resource is ClinicalTrials.gov, a registry maintained by the National Institutes of Health that lists clinical studies worldwide. You can search by condition (such as “COPD,” “chronic bronchitis,” or “emphysema”), location, and recruitment status. Each listing describes the purpose, eligibility criteria, locations, and contacts. The National Heart, Lung, and Blood Institute (NHLBI) also shares information about lung research.
Academic pulmonary centers and lung-health advocacy organizations may list opportunities as well. Read eligibility rules closely: inclusion criteria (characteristics you must have) and exclusion criteria (things that would keep you out), which often include COPD severity, smoking history, age, prior treatments, and other conditions. For general context, our wellness guides take an evidence-first approach, and our overview of supplements studied for immune support covers what the evidence does and does not show.
Informed consent and your rights
Before joining any trial, you go through informed consent. The research team must explain the study’s purpose, procedures, potential risks and benefits, alternatives, and what is expected of you, in language you can understand, and give you time to ask questions. Key protections include:
- Participation is voluntary, and declining will not affect your regular care.
- You can withdraw at any time, for any reason.
- Trials are reviewed by an independent ethics board (an Institutional Review Board).
- You should understand any costs, travel, time commitment, and what happens when the study ends.
Consent is an ongoing conversation, not just a signature. The same participant protections apply across conditions, as in our guide to clinical trials for macular degeneration.
Talk with your pulmonologist first
A trial is a medical decision, so involve the doctor who manages your COPD. Your pulmonologist can help you weigh whether a study fits your situation, what the realistic pros and cons are, and how it interacts with your current treatment. Never stop or change your inhalers, oxygen, or other treatment on your own to qualify for a trial; abrupt changes can worsen breathing and trigger flare-ups. Let your care team and the research team coordinate any changes safely.
Frequently asked questions
Will a trial cure my COPD? No trial can promise that. COPD is a chronic condition; trials test whether treatments are safe and effective, and benefit is possible but not guaranteed. Many studies aim to improve symptoms or reduce flare-ups.
Where do I find COPD trials? ClinicalTrials.gov is the main US registry; NHLBI is another resource. Academic pulmonary programs may also list studies.
Might I get a placebo? In some trials, yes. Randomized, blinded designs may assign a comparison or placebo group, which the consent process explains.
Do I have to pay? Study treatment is often provided, but costs vary. Ask about expenses, travel, and coverage before enrolling.
Can I leave after starting? Yes. Participation is voluntary, and you can withdraw at any time without losing access to your standard care.
Should I stop my inhaler to qualify? Never on your own. Any change must be guided by your pulmonologist and the research team.
This article is for general education and is not medical advice. Supplements and therapies affect people differently and can interact with medications or conditions. Talk to your doctor, pharmacist, or a licensed clinician before making changes to your health routine.
Sources
- ClinicalTrials.gov — US registry of clinical studies and how to search it
- National Heart, Lung, and Blood Institute (NHLBI) — COPD and lung research information
- National Institutes of Health (NIH) — basics of clinical trials and participant protections
- U.S. Food and Drug Administration (FDA) — clinical trial phases and drug development
- MedlinePlus — clinical trials and COPD overviews